IPN60090

· Ipsen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IPN60090, covering 2021-11-22 to 2021-11-22. Get the full timeline:

Most recent: Clinical Trial Update: Dose Escalation and Dose Expansion Study of IPN60090 in Patients With Advanced Solid Tumours [Phase 1]